Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128874) titled 'Efficacy, Safety, and Inflammation-Metabolism Association of Esketamine Nasal Spray Versus Modified Electroconvulsive Therapy for Depression With Acute Suicidal Ideation' on July 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second General Hospital of Fuzhou Neuropsychiatric prevention and treatment Hospital
Condition:
Major Depressive Disorder, MDD
Intervention:
Control group:modified electroconvulsive therapy, MECT
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Control group:50;Experimental group:50;
Count...